Article

The New York TimesThe New York Times on 2019-08-08 01:39

Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.

Responding to the agency’s stern rebuke, Vas Narasimhan, the company’s executive, tried to reassure investors that Novartis did not intentionally ...

Related news